Brief: Medmix H1 Adjusted EBITDA CHF 44.9 Million
Jul 23 (Reuters) - Medmix H1 free cash flow CHF 11.4 million. H1 adjusted EBITDA margin 19.9% H1 revenue CHF 225.4 million
Jul 23 (Reuters) - Medmix H1 free cash flow CHF 11.4 million. H1 adjusted EBITDA margin 19.9% H1 revenue CHF 225.4 million